MediciNova Earnings Call Transcripts

Fiscal Year 2026

H.C. Wainwright 28th Annual Global Investment Conference

Two pivotal clinical readouts—MN-001 in September and COMBAT-ALS by year-end—are set to drive near-term value, supported by a strong cash position and a lean, capital-efficient model. Externally funded programs and regulatory designations add further optionality.

Read full transcript →